Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind placebo-controlled study of TAK-438 in non-erosive gastroesophageal reflux disease
jRCT2080221622Phase 3
- Sponsor
- Takeda
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vonoprazan in Non-erosive Gastroesophageal Reflux Disease (NERD) (3 arms), sponsored by Takeda.
02
Drugs
vonoprazan
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on jRCT2080221622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221622.